Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
154.30    1.80 (1.18%)
Bid:
154.00
Ask:
154.50
Spread: 0.50 (0.325%)
Market Cap: £1.60b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

Form 8.5 (EPT/RI)

15 Mar 2024 09:06

RNS Number : 0418H
Citigroup Global Markets Limited
15 March 2024
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Currys plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Currys plc

(d) Date dealing undertaken:

14 March 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

 If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

0.1p ordinary

Sale

466,200

GBP 0.6015

GBP 0.5870

0.1p ordinary

Purchase

466,200

GBP 0.6007

GBP 0.5885

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

 e.g. CFD

Nature of dealing

 e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description

 e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

 e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

 e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

 e.g. subscription, conversion

Details

Price per unit (if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

 Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

15 March 2024

Contact name:

Craig Watson

Telephone number:

02890 409 605

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGZGMFLKMGDZG
Date   Source Headline
18th Jan 20247:00 amRNSStrengthening performance in a tough environment
2nd Jan 202412:52 pmRNSTotal Voting Rights
21st Dec 20232:54 pmRNSHolding(s) in Company
21st Dec 202310:40 amRNSHolding(s) in Company
20th Dec 20239:54 amRNSHolding(s) in Company
14th Dec 20235:24 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSSolid performance in a tough environment
1st Dec 20239:06 amRNSTotal Voting Rights
21st Nov 202312:01 pmRNSResult of Meeting
3rd Nov 202312:25 pmRNSShareholder Circular and Notice of General Meeting
3rd Nov 20237:05 amRNSProposed Disposal of Kotsovolos
1st Nov 20239:41 amRNSTotal Voting Rights
10th Oct 20237:27 amRNSUpdate on Strategic Review of Kotsovolos
6th Oct 20233:16 pmRNSHolding(s) in Company
2nd Oct 202311:26 amRNSTotal Voting Rights
28th Sep 202310:55 amRNSHolding(s) in Company
20th Sep 202310:35 amRNSDirector/PDMR Shareholding
19th Sep 202310:35 amRNSHolding(s) in Company
7th Sep 20231:51 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM Trading Statement
1st Sep 20239:09 amRNSTotal Voting Rights
22nd Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 202312:40 pmRNSDirector/PDMR Shareholding
4th Aug 20239:44 amRNSDirector/PDMR Shareholding
3rd Aug 202312:54 pmRNSAnnual Financial Report
3rd Aug 20239:25 amRNSDirector/PDMR Shareholding
1st Aug 202311:09 amRNSTotal Voting Rights
28th Jul 202310:58 amRNSDirector/PDMR Shareholding
13th Jul 20238:30 amRNSHolding(s) in Company
12th Jul 20234:14 pmRNSHolding(s) in Company
11th Jul 20239:42 amRNSHolding(s) in Company
10th Jul 20232:59 pmRNSDirector/PDMR Shareholding
7th Jul 202310:36 amRNSDirector/PDMR Shareholding
6th Jul 20231:26 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSStrengthening UK&I offset by poor Nordics
3rd Jul 20239:55 amRNSTotal Voting Rights
26th Jun 202312:14 pmRNSHolding(s) in Company
23rd Jun 20234:23 pmRNSHolding(s) in Company
22nd Jun 20239:22 amRNSHolding(s) in Company
19th Jun 20235:20 pmRNSHolding(s) in Company
19th Jun 20234:38 pmRNSHolding(s) in Company
16th Jun 20237:00 amRNSStrategic Review of Kotsovolos
2nd Jun 202310:37 amRNSDirectorate Change
1st Jun 20239:33 amRNSTotal Voting Rights
24th May 20238:37 amRNSResponse to ESA announcement
15th May 20237:00 amRNSTrading Statement
3rd May 20235:21 pmRNSHolding(s) in Company
2nd May 202311:43 amRNSTotal Voting Rights
11th Apr 20235:53 pmRNSHolding(s) in Company
5th Apr 202310:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.